"We create companies that didn't exist before, and we create jobs that didn't exist before, " says Jonathan Silver, managing director of Core Capital Partners, a Washington, D.
But Josephine Quintavalle, director of Comment on Reproductive Ethics (Core), which opposes embryonic stem cell therapies, dismissed the research as "highly speculative".